NIH seeks applications for a clinical trials network to evaluate interventions for emerging and chronic infections and support early-career investigators and those new to the field.
This grant has transitioned from forecasted to posted and is now accepting applications.
NIH funds continuation of the Immune Tolerance Network to develop tolerogenic therapies through clinical trials and mechanistic studies in allergy, asthma, autoimmunity, and transplantation.
This grant supports innovative solutions to improve the design, efficiency, and impact of multi-center clinical trials through the Trial Innovation Network, focusing on safety, training, digital health, genomics, and disease modeling.
National Cancer Institute funds early phase clinical trials for cancer treatment and diagnosis, focusing on targeted interventions relevant to specific research programs.
NIH seeks to support clinical research sites for NeuroNEXT to advance neurological disorder trials and biomarker studies by providing infrastructure and collaboration opportunities.
The NIH plans to continue funding centers that coordinate clinical trials and data management for NeuroNEXT, advancing research and therapies for neurological disorders in adults and children.